Drug Type CAR-T |
Synonyms TMMSTN02 |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lung Cancer | Preclinical | United States | - | |
| Mesothelioma | Preclinical | United States | - | |
| Ovarian Epithelial Carcinoma | Preclinical | United States | - | |
| Pancreatic Cancer | Preclinical | United States | - |





